我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
31
4 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
1
3.2%
已完成
24
77.4%
尚未招募
3
9.7%
招募中
暂无批准数据
- The ESPRESSo trial found that high-intensity therapy starting within two weeks of stroke did not improve hand and arm recovery beyond standard care, challenging the "more therapy, earlier" approach. - Sixty-four stroke survivors received an extra 90 minutes of daily therapy for three weeks, but showed identical three-month outcomes to patients receiving standard care alone. - The study suggests early stroke recovery is dominated by natural biological repair processes that cannot be enhanced by increasing therapy dose above standard care. - Results indicate that intensive therapy may be more effective later in recovery when patients can engage more fully, rather than during the acute phase.
